Global point of care
Webinars
Should you screen for kidney damage? What do the guidelines say?
Published February 23, 2023
Summary
Chronic kidney disease is a common and often silent condition - up to one in ten adults could be affected, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether - which is why testing in at-risk groups is so important. In this webinar series of 20 minutes each learn how early detection can slow disease progression or even prevent it altogether.
Our international speakers discuss the role of rapid diagnostics in disease prevention with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.
Learn more about current guidelines and kidney disease prevention and management.
Learning Objectives
- Importance of regular testing for early detection and monitoring in high-risk patients
- Importance of ACR testing beside the determination of eGFR
- Latest guidance on disease prevention and management
- Case studies
References
- Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
Presenter Biography
Dr. Peter Rossing
Denmark
Head of department for complications research at Steno Diabetes center Copenhagen, and Professor in Endocrinology at Department of Clinical Medicine, University of Copenhagen
Who Should Watch
Healthcare Professionals, Physicians, Clinicians, Nurses, POC Coordinators, ED Physicians, Lab Director, Emergency Medicine Directors
